Charles Dushack, DPM
Foot & Ankle Surgery · Fort Myers, FLNPI 1518167428
Payments from drug & device makers
What this record shows
This record is dominated by other: $27,400 of the $29,036 with a category attached, or 94.4%. Biolab Sciences, Inc. accounts for 94.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $27,709 and has fallen 99.9% since, to $27 in 2024. Among foot & ankle surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 18 payments — averaging $1613.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biolab Sciences, Inc.$27K
- Arthrex$1K
- MVP Orthopedics Inc$309
- Stryker$74
- Reprise Biomedical, Inc.$27
- Biocomposites Inc$27
- plus $62 from 3 others
What the payments were for
- Food & beverage$8303%
- Education$8063%
- Other$27,40094%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biolab Sciences, Inc. | 1 | $27,400 |
| Arthrex | 7 | $1,137 |
| MVP Orthopedics Inc | 4 | $309 |
| Stryker | 1 | $74 |
| Reprise Biomedical, Inc. | 1 | $27 |
| Biocomposites Inc | 1 | $27 |
| Organogenesis Inc. | 1 | $24 |
| Aroa Biosurgery Incorporated | 1 | $21 |
| Coastal Medical Technologies LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$29,036 in reported general payments places this provider in the 90th percentile of 850 foot & ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 41 | $760 |
| Gabapentin | 55 | $335 |
| Cephalexin | 48 | $258 |
| Ciprofloxacin Hcl | 16 | $204 |
| Methylprednisolone | 30 | $185 |
| Clindamycin Hcl | 21 | $121 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $65 |
| Tramadol Hcl | 13 | $39 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Fort Myers
- Andrew BelisFort Myers$206K
- Chad SimmonsFort Myers$60K
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$861K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$785K
- Mario CalaHialeah$541K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.